Ameriprise
ASPX

Ameriprise’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Ameriprise’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-94,547
Closed -$9.48M – 4160
2015
Q1 		$9.48M Sell
94,547
-89,664
-49% -$5.97M 0.01% 1601
2014
Q4 		$9.67M Sell
184,211
-257,636
-58% -$7.57M 0.01% 1527
2014
Q3 		$11.3M Buy
441,847
+99,418
+29% +$2.12M 0.01% 1360
2014
Q2 		$7.63M Sell
342,429
-37,195
-10% -$814K ﹤0.01% 1761
2014
Q1 		$11.7M Buy
+379,624
New +$10.2M 0.01% 1382

Ameriprise's ASPX Position: Q2 2015 in Review

Ameriprise sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 94,547 shares — an estimated $9.48M sold.

Ameriprise first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $11.7M in Q1 2014. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Ameriprise reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Ameriprise sold 94,547 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $9.48M.
  • Ameriprise first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • Ameriprise's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $11.7M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Ameriprise's 13F filing for Q2 2015, filed 13 Aug 2015.